Jeanne Marrazzo, MD, MPH
Dr. Marrazzo is a scientific leader in the fields of STI and HIV prevention, microbiology, and the microbiome of the female genital tract. Her extensive experience studying conducting translational research, evaluating the epidemiologic and clinical features of STI in national and international settings combined with my experience studying interventions to improve vaginal health support her important role in this effort. Dr. Marrazzo’s methodological expertise includes HIV/STI epidemiology, molecular microbiology and clinical trials. She has been centrally involved in numerous prospective studies of sexually transmitted infections (STI) and conducted several studies within the framework of the NIH-funded STI Clinical Trials Group (CTG), and currently chairs the Microbicide Trails Network (MTN) Biomedical Science Working Group. Since 2007, she has been the Protocol Co-Chair leading the VOICE (MTN 003) study, a large trial that studied HIV pre-exposure prophylaxis (PrEP) administered vaginally and orally to over 5,000 women at high risk for HIV infection in sub-Saharan Africa. While at the University of Washington, she led the successful application as PI to re-establish the NIH-funded STI Cooperative Research Centers (CRC) U19, whose theme was the interaction between the human genital microbiome, local immunity, and STI susceptibility. She currently services as Co-Director of the UAB STI CRC.